Myeloma Trial, Recruiting (NCT02682667)

Myeloma Trial, Recruiting NCT02682667 Sponsor: National Cancer Institute (NCI) Condition: Myeloma

Printed from Voxsanity (voxsanity.com.au) — NCT02682667 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Myeloma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with cancer, a pre-cancerous condition, or a disease (such as an immune system disorder) that raises your risk of developing cancer or a pre-cancerous condition
You are 18 years of age or older
You are reasonably functional in daily life — not fully bedridden (your doctor can confirm this based on a standard activity scale called ECOG, scored 0–3) (confirm with trial site)
You are able and willing to give your formal agreement to take part in the study

If you are also having a blood collection procedure called apheresis, these additional requirements apply:

Your blood counts (red blood cells and platelets) are at or above certain minimum levels (confirm with trial site)
You weigh at least 48 kg (approximately 106 lbs)
You have a suitable way for blood to be collected, either through a central line or good enough veins in your arm (confirm with trial site)

Who may not be able to join:

You have an active medical or mental health condition that could put you at extra risk by taking part in the trial
You are not able to give your formal agreement to take part in the study
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Scott M Norberg, D.O., National Cancer Institute (NCI)

Phone: (301) 275-9668

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02682667

Sponsor: National Cancer Institute (NCI)

Phase: Not Applicable

Status: Recruiting

Condition: Myeloma

Trial contact: (301) 275-9668

More information: https://clinicaltrials.gov/study/NCT02682667

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with cancer, a pre-cancerous condition, or a disease (such as an immune system disorder) that raises your risk of developing cancer or a pre-cancerous condition
You are 18 years of age or older
You are reasonably functional in daily life — not fully bedridden (your doctor can confirm this based on a standard activity scale called ECOG, scored 0–3) (confirm with trial site)
You are able and willing to give your formal agreement to take part in the study

If you are also having a blood collection procedure called apheresis, these additional requirements apply:

Your blood counts (red blood cells and platelets) are at or above certain minimum levels (confirm with trial site)
You weigh at least 48 kg (approximately 106 lbs)
You have a suitable way for blood to be collected, either through a central line or good enough veins in your arm (confirm with trial site)

Who may not be able to join:

You have an active medical or mental health condition that could put you at extra risk by taking part in the trial
You are not able to give your formal agreement to take part in the study
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Cancer Institute (NCI)

Registry

ClinicalTrials.gov

Start date

11 April 2016

Est. completion

1 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Sample Acquisition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov